Skip to content
iCo Therapeutics
  • iCo Therapeutics
  • About Us ▾
    • Our Vision and Strategy
    • Leadership and Board of Directors
    • Accomplishments
  • Current Assets ▾
    • The Problem of Drug Shortages
    • iCo-008
    • Oral Amphotericin B
  • Investor Information
  • Contact
  • iCo Articles

2007 News Releases

2007 News Releases

Dec 31, 2007:

iCo Therapeutics Inc. and Beanstalk Capital Ltd. Announce Completion of Arrangement

Oct 31, 2007:

Beanstalk Capital Ltd. and iCo Therapeutics Inc. amend arrangement agreement

Oct 16, 2007:

Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc.

Oct 9, 2007:

Isis Receives $1.25 Million Milestone Payment From iCo for Initiation of Phase 1 Study of iCo-007

Jan 22, 2007:

iCo Therapeutics Receives FDA Clearance to Initiate Clinical Trial in Diabetic Macular Edema

Jan 10, 2007:

iCo Therapeutics announces licensing deal

Jan 8, 2007:

Cambridge Antibody Tech. licenses monoclonal antibody for treatment of allergy disorders to iCo

Contact Us

 About iCo

 Sitemap

  The Development of Research

© Copyright 2022 - iCo Therapeutics Inc. - All Rights Reserved.